News Agency
The Times

Biotheus Enters Into Strategic Partnership with BioNTech to Develop and Commercialize Bispecific Antibody Candidate Targeting PD-L1 and VEGF in Multiple Solid Tumor Indications

  • Written by PR Newswire

Bispecific Antibody Candidate PM8002 demonstrated encouraging data at this year's ASCO Annual Meeting (abstract #2536 & #e13091) and ESMO Congress (abstract #1992P)

BioNTech will hold exclusive licenses to develop and commercialize PM8002 globally excluding Greater China  

ZHUHAI, China, Nov. 6, 2023 /PRNewswire/ -- Biotheus Inc....

Read more: Biotheus Enters Into Strategic Partnership with BioNTech to Develop and Commercialize Bispecific...

Practical Ways to Help Reduce the Risk of Costly Business Disputes

Business disputes have a way of draining time, money and energy that could be better spent running your operation. While not every disagreement can be prevented, many disputes stem from issues that better planning may have reduced or avoided. Taking... Read more

Writers Wanted



NewsServices.com

Content & Technology Connecting Global Audiences

More Information - Less Opinion